BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17496363)

  • 1. The role of AMP kinase in diabetes.
    Misra P; Chakrabarti R
    Indian J Med Res; 2007 Mar; 125(3):389-98. PubMed ID: 17496363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase: Role in metabolism and therapeutic implications.
    Schimmack G; Defronzo RA; Musi N
    Diabetes Obes Metab; 2006 Nov; 8(6):591-602. PubMed ID: 17026483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the AMP-activated protein kinase for the treatment of type 2 diabetes.
    Musi N; Goodyear LJ
    Curr Drug Targets Immune Endocr Metabol Disord; 2002 Jul; 2(2):119-27. PubMed ID: 12476786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AMP-activated protein kinase and type 2 diabetes.
    Musi N
    Curr Med Chem; 2006; 13(5):583-9. PubMed ID: 16515522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMP activated protein kinase: a next generation target for total metabolic control.
    Misra P
    Expert Opin Ther Targets; 2008 Jan; 12(1):91-100. PubMed ID: 18076373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of glucose transport by the AMP-activated protein kinase.
    Fujii N; Aschenbach WG; Musi N; Hirshman MF; Goodyear LJ
    Proc Nutr Soc; 2004 May; 63(2):205-10. PubMed ID: 15294031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and chronic treatment of ob/ob and db/db mice with AICAR decreases blood glucose concentrations.
    Halseth AE; Ensor NJ; White TA; Ross SA; Gulve EA
    Biochem Biophys Res Commun; 2002 Jun; 294(4):798-805. PubMed ID: 12061777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and fuel homeostasis: the role of AMP-activated protein kinase.
    Hegarty BD; Turner N; Cooney GJ; Kraegen EW
    Acta Physiol (Oxf); 2009 May; 196(1):129-45. PubMed ID: 19245658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. α2 isoform-specific activation of 5'adenosine monophosphate-activated protein kinase by 5-aminoimidazole-4-carboxamide-1-β-D-ribonucleoside at a physiological level activates glucose transport and increases glucose transporter 4 in mouse skeletal muscle.
    Nakano M; Hamada T; Hayashi T; Yonemitsu S; Miyamoto L; Toyoda T; Tanaka S; Masuzaki H; Ebihara K; Ogawa Y; Hosoda K; Inoue G; Yoshimasa Y; Otaka A; Fushiki T; Nakao K
    Metabolism; 2006 Mar; 55(3):300-8. PubMed ID: 16483872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [AMPK as a cellular energy sensor and its function in the organism].
    Miranda N; Tovar AR; Palacios B; Torres N
    Rev Invest Clin; 2007; 59(6):458-69. PubMed ID: 18402338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle.
    Olsen GS; Hansen BF
    Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E965-70. PubMed ID: 12376323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for AMP-activated protein kinase in diabetes-induced renal hypertrophy.
    Lee MJ; Feliers D; Mariappan MM; Sataranatarajan K; Mahimainathan L; Musi N; Foretz M; Viollet B; Weinberg JM; Choudhury GG; Kasinath BS
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F617-27. PubMed ID: 17018841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gly-Ala-Gly-Val-Gly-Tyr, a novel synthetic peptide, improves glucose transport and exerts beneficial lipid metabolic effects in 3T3-L1 adipoctyes.
    Kim ED; Kim E; Lee JH; Hyun CK
    Eur J Pharmacol; 2011 Jan; 650(1):479-85. PubMed ID: 20951125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
    Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of AMPK is essential for AICAR-induced glucose uptake by skeletal muscle but not adipocytes.
    Sakoda H; Ogihara T; Anai M; Fujishiro M; Ono H; Onishi Y; Katagiri H; Abe M; Fukushima Y; Shojima N; Inukai K; Kikuchi M; Oka Y; Asano T
    Am J Physiol Endocrinol Metab; 2002 Jun; 282(6):E1239-44. PubMed ID: 12006353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
    Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
    Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caffeine acutely activates 5'adenosine monophosphate-activated protein kinase and increases insulin-independent glucose transport in rat skeletal muscles.
    Egawa T; Hamada T; Kameda N; Karaike K; Ma X; Masuda S; Iwanaka N; Hayashi T
    Metabolism; 2009 Nov; 58(11):1609-17. PubMed ID: 19608206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activators of AMP-activated protein kinase enhance GLUT4 translocation and its glucose transport activity in 3T3-L1 adipocytes.
    Yamaguchi S; Katahira H; Ozawa S; Nakamichi Y; Tanaka T; Shimoyama T; Takahashi K; Yoshimoto K; Imaizumi MO; Nagamatsu S; Ishida H
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E643-9. PubMed ID: 15928020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in the development of AMPK-activating compounds.
    Sriwijitkamol A; Musi N
    Expert Opin Drug Discov; 2008 Oct; 3(10):1167-76. PubMed ID: 23489075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity.
    Kim WS; Lee YS; Cha SH; Jeong HW; Choe SS; Lee MR; Oh GT; Park HS; Lee KU; Lane MD; Kim JB
    Am J Physiol Endocrinol Metab; 2009 Apr; 296(4):E812-9. PubMed ID: 19176354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.